Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xethanol Corporation was a biotechnology company focused on the production of ethanol and other renewable chemicals from biomass. The company specialized in cellulosic ethanol technology, utilizing chemical and fermentation processes to convert waste materials like wood chips, agricultural residue, and municipal solid waste into fuel. Headquartered in New York, Xethanol aimed to provide sustainable alternatives to petroleum-based fuels through its proprietary biomass-to-ethanol platform. The company operated several production facilities and sought to commercialize technologies licensed from academic and government institutions. While it was a pioneer in the mid-2000s biofuels boom, the company faced significant operational challenges and eventually transitioned its business model, rebranding as Global Clean Energy Holdings in 2008.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xethanol BioFuels.